Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

pcDNA3.2/v5-DEST hGlut1 Citations (5)

Originally described in: Facilitative plasma membrane transporters function during ER transit.
Takanaga H, Frommer WB FASEB J. 2010 Aug . 24(8):2849-58.
PubMed Journal

Articles Citing pcDNA3.2/v5-DEST hGlut1

Articles
Dihydroartemisinin inhibits glucose uptake and cooperates with glycolysis inhibitor to induce apoptosis in non-small cell lung carcinoma cells. Mi YJ, Geng GJ, Zou ZZ, Gao J, Luo XY, Liu Y, Li N, Li CL, Chen YQ, Yu XY, Jiang J. PLoS One. 2015 Mar 23;10(3):e0120426. doi: 10.1371/journal.pone.0120426. eCollection 2015. PubMed
GLUT3 upregulation promotes metabolic reprogramming associated with antiangiogenic therapy resistance. Kuang R, Jahangiri A, Mascharak S, Nguyen A, Chandra A, Flanigan PM, Yagnik G, Wagner JR, De Lay M, Carrera D, Castro BA, Hayes J, Sidorov M, Garcia JL, Eriksson P, Ronen S, Phillips J, Molinaro A, Koliwad S, Aghi MK. JCI Insight. 2017 Jan 26;2(2):e88815. doi: 10.1172/jci.insight.88815. PubMed
Cytoplasmic p53 couples oncogene-driven glucose metabolism to apoptosis and is a therapeutic target in glioblastoma. Mai WX, Gosa L, Daniels VW, Ta L, Tsang JE, Higgins B, Gilmore WB, Bayley NA, Harati MD, Lee JT, Yong WH, Kornblum HI, Bensinger SJ, Mischel PS, Rao PN, Clark PM, Cloughesy TF, Letai A, Nathanson DA. Nat Med. 2017 Nov;23(11):1342-1351. doi: 10.1038/nm.4418. Epub 2017 Oct 9. PubMed
GLUT1 protects prostate cancer cells from glucose deprivation-induced oxidative stress. Gonzalez-Menendez P, Hevia D, Alonso-Arias R, Alvarez-Artime A, Rodriguez-Garcia A, Kinet S, Gonzalez-Pola I, Taylor N, Mayo JC, Sainz RM. Redox Biol. 2018 Jul;17:112-127. doi: 10.1016/j.redox.2018.03.017. Epub 2018 Apr 12. PubMed
MIG-6 is essential for promoting glucose metabolic reprogramming and tumor growth in triple-negative breast cancer. He J, Li CF, Lee HJ, Shin DH, Chern YJ, Pereira De Carvalho B, Chan CH. EMBO Rep. 2021 May 5;22(5):e50781. doi: 10.15252/embr.202050781. Epub 2021 Mar 3. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.